Bosh sahifaSUNPHARMA • NSE
add
Sun Pharmaceutical Industries Ltd
Yopilish kursi
1 741,65 ₹
Kunlik diapazon
1 728,65 ₹ - 1 751,15 ₹
Yillik diapazon
1 068,35 ₹ - 1 758,00 ₹
Bozor kapitalizatsiyasi
4,16 trln INR
Oʻrtacha hajm
2,08 mln
Narx/foyda
39,98
Dividend daromadliligi
0,78%
Asosiy maydon
NSE
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 126,53 mlrd | 5,96% |
Joriy xarajat | 69,74 mlrd | 7,23% |
Sof foyda | 28,36 mlrd | 40,20% |
Sof foyda marjasi | 22,41 | 32,29% |
Har bir ulushga tushum | 11,80 | 24,37% |
EBITDA | 35,92 mlrd | 10,02% |
Amaldagi soliq stavkasi | 16,18% | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 190,90 mlrd | 26,17% |
Jami aktivlari | — | — |
Jami passivlari | — | — |
Umumiy kapital | 671,06 mlrd | — |
Tarqatilgan aksiyalar | 2,40 mlrd | — |
Narxi/balansdagi bahosi | 6,56 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | 10,67% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 28,36 mlrd | 40,20% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. Wikipedia
Tashkil etilgan
1983
Bosh ofis
Sayt
Xodimlar soni
43 000
